drugset / Trial / NCT03579940
A Study of Lasmiditan in Healthy Japanese and Caucasian Participants
RandomizedCrossoverDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and tolerability of lasmiditan in healthy Japanese and Caucasian participants. The study will also investigate how much lasmiditan gets into the bloodstream and how long it takes the body to get rid of lasmiditan when given to Japanese and Caucasians. The study will last up to 47 days for each participant.
Timeline
- Start
- 2018-06-27
- Primary completion
- 2018-08-09
- Completion
- 2018-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lasmiditan | Small molecule | 50 mg | Oral |
| Subject | Lasmiditan | Small molecule | 100 mg | Oral |
| Subject | Lasmiditan | Small molecule | 200 mg | Oral |
| Subject | Lasmiditan | Small molecule | 400 mg | Oral |
Indications
No indication recorded.